Literature DB >> 25038584

Impact of MYC in regulation of tumor cell metabolism.

Therese Wahlström1, Marie Arsenian Henriksson2.   

Abstract

The MYC proto-oncoproteins including c-MYC, MYCN and MYCL exert their functions as heterodimers with MAX, which in turn binds to E-box sequences at target promoters to regulate gene expression. It has been shown that MYC binds to 10-15% of all promoter regions and regulates genes involved in a wide variety of cellular functions. In normal cells the expression of MYC is tightly controlled whereas it is deregulated in the majority of human tumors. MYC contributes to malignant transformation by promoting multiple processes including uncontrolled cell proliferation, cell growth and genomic instability. Importantly, MYC promotes growth by activating genes involved in ribosomal and mitochondrial biogenesis, glucose and glutamine metabolism as well as lipid synthesis. Hence, MYC is contributing to the metabolic reprogramming essential for cancer cells to adapt to the tumor microenvironment. Here we give an overview of the role of MYC in regulation of metabolic pathways in tumor cells. This article is part of a Special Issue entitled: MYC proteins in cell biology and pathology.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; MYC; Metabolic reprogramming; Metabolism; Mitochondria

Mesh:

Substances:

Year:  2014        PMID: 25038584     DOI: 10.1016/j.bbagrm.2014.07.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  65 in total

Review 1.  Patterns of Chromosomal Aberrations in Solid Tumors.

Authors:  Marian Grade; Michael J Difilippantonio; Jordi Camps
Journal:  Recent Results Cancer Res       Date:  2015

Review 2.  Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms.

Authors:  Ning Zhang; Weihua Lou; Fang Ji; Lihua Qiu; Benjamin K Tsang; Wen Di
Journal:  J Cancer Res Clin Oncol       Date:  2016-02-24       Impact factor: 4.553

3.  The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

Authors:  Arvin M Gouw; Katherine Margulis; Natalie S Liu; Sudha J Raman; Anthony Mancuso; Georgia G Toal; Ling Tong; Adriane Mosley; Annie L Hsieh; Delaney K Sullivan; Zachary E Stine; Brian J Altman; Almut Schulze; Chi V Dang; Richard N Zare; Dean W Felsher
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

4.  Inhibition of mTORC1 signaling sensitizes hepatocellular carcinoma cells to glycolytic stress.

Authors:  Xin Zhao; Peng Jiang; Xiang Deng; Zhonghu Li; Feng Tian; Fei Guo; Xiaowu Li; Shuguang Wang
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

Review 5.  Wnts and the hallmarks of cancer.

Authors:  Zheng Zhong; Jia Yu; David M Virshup; Babita Madan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 6.  Dendritic cell metabolism.

Authors:  Edward J Pearce; Bart Everts
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

7.  Metabolic and oncogenic adaptations to pyruvate dehydrogenase inactivation in fibroblasts.

Authors:  Huabo Wang; Jie Lu; Sucheta Kulkarni; Weiqi Zhang; Joanna E Gorka; Jordan A Mandel; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-02-12       Impact factor: 5.157

Review 8.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

9.  Metabolomic profiling of mouse mammary tumor-derived cell lines reveals targeted therapy options for cancer subtypes.

Authors:  Martin P Ogrodzinski; Shao Thing Teoh; Sophia Y Lunt
Journal:  Cell Oncol (Dordr)       Date:  2020-07-20       Impact factor: 6.730

10.  Chronic Hexavalent Chromium Exposure Induces Cancer Stem Cell-Like Property and Tumorigenesis by Increasing c-Myc Expression.

Authors:  Zhishan Wang; Hsuan-Pei Lin; Yunfei Li; Hua Tao; Ping Yang; Jie Xie; Drew Maddy; Kazuya Kondo; Chengfeng Yang
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.